FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983212741> ?p ?o ?g. }

• W1983212741 endingPage "841" @default.
• W1983212741 startingPage "835" @default.
• W1983212741 abstract "Our objective was to assess the antitumoral activity and toxicity of irinotecan (CPT-11) 60-min i.v. infusion every 2 weeks as second-line monotherapy of advanced colorectal cancer. Two doses were studied (250 and 200 mg/m) according to the risk of developing toxicity. Two groups of patients were studied: high-risk group (HR, 200 mg/m, n = 45; Karnofsky score 60-80% and/or the record of prior pelvic irradiation) and low-risk-group (LR, 250 mg/m, n = 51; Karnofsky score >80% and without prior pelvic irradiation). The mean number of cycles per patient was 7: 6.6 (HR group) and 8.3 (LR group). Median RDI was 0.96. The overall response rate was 8.9% [95% confidence interval (CI) 2.5-21.2%; HR group] and 15.7% (95% CI 7.0-28.5%; LR group), respectively. The LR group showed two complete responses and a higher percentage of stable disease (56.9 versus 33.3% in HR group). The median survival was 7.1 months (95% CI 5.2-8.9 months, HR group) and 11.7 months (95% CI 8.4-15.1 months, LR group). The median time to disease progression was 3.2 months (95% CI 1.0-5.4 months, HR group) and 5.3 months (95% CI 3.8-6.7 months, LR group). Both CPT-11 treatments were well tolerated. Grade 3/4 toxicity incidence was low, e.g. granulocytopenia (7% of patients in HR group and 9% in LR group) and delayed diarrhea (18% of patients in HR group and 14% in LR group). We conclude that the treatment of patients with the adjusted dose of CPT-11 according to prognostic factors for toxicity resulted in the improved toxicity profile, but showed poorer efficacy outcome. Therefore, the dose reduction in patients with low performance and treated with radiotherapy needs further investigation to provide some new insights on the benefit:risk ratio of such treatment." @default.
• W1983212741 created "2016-06-24" @default.
• W1983212741 creator A5003168923 @default.
• W1983212741 creator A5013581346 @default.
• W1983212741 creator A5032330636 @default.
• W1983212741 creator A5034478855 @default.
• W1983212741 creator A5040563108 @default.
• W1983212741 creator A5045627245 @default.
• W1983212741 creator A5058891467 @default.
• W1983212741 creator A5061545647 @default.
• W1983212741 creator A5079628452 @default.
• W1983212741 creator A5080029303 @default.
• W1983212741 date "2004-10-01" @default.
• W1983212741 modified "2023-10-18" @default.
• W1983212741 title "Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factors" @default.
• W1983212741 cites W1585255446 @default.
• W1983212741 cites W1774923611 @default.
• W1983212741 cites W181158363 @default.
• W1983212741 cites W1832060645 @default.
• W1983212741 cites W1969861347 @default.
• W1983212741 cites W1984254136 @default.
• W1983212741 cites W2006824814 @default.
• W1983212741 cites W2025163366 @default.
• W1983212741 cites W2066546242 @default.
• W1983212741 cites W2096122707 @default.
• W1983212741 cites W2110650955 @default.
• W1983212741 cites W2136453526 @default.
• W1983212741 cites W2167805334 @default.
• W1983212741 cites W2169186295 @default.
• W1983212741 cites W2246769930 @default.
• W1983212741 cites W2308212596 @default.
• W1983212741 cites W2314927739 @default.
• W1983212741 doi "https://doi.org/10.1097/00001813-200410000-00003" @default.
• W1983212741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15457123" @default.
• W1983212741 hasPublicationYear "2004" @default.
• W1983212741 type Work @default.
• W1983212741 sameAs 1983212741 @default.
• W1983212741 citedByCount "6" @default.
• W1983212741 countsByYear W19832127412022 @default.
• W1983212741 crossrefType "journal-article" @default.
• W1983212741 hasAuthorship W1983212741A5003168923 @default.
• W1983212741 hasAuthorship W1983212741A5013581346 @default.
• W1983212741 hasAuthorship W1983212741A5032330636 @default.
• W1983212741 hasAuthorship W1983212741A5034478855 @default.
• W1983212741 hasAuthorship W1983212741A5040563108 @default.
• W1983212741 hasAuthorship W1983212741A5045627245 @default.
• W1983212741 hasAuthorship W1983212741A5058891467 @default.
• W1983212741 hasAuthorship W1983212741A5061545647 @default.
• W1983212741 hasAuthorship W1983212741A5079628452 @default.
• W1983212741 hasAuthorship W1983212741A5080029303 @default.
• W1983212741 hasConcept C121608353 @default.
• W1983212741 hasConcept C126322002 @default.
• W1983212741 hasConcept C141071460 @default.
• W1983212741 hasConcept C2776694085 @default.
• W1983212741 hasConcept C2780259306 @default.
• W1983212741 hasConcept C2780456651 @default.
• W1983212741 hasConcept C29730261 @default.
• W1983212741 hasConcept C44249647 @default.
• W1983212741 hasConcept C526805850 @default.
• W1983212741 hasConcept C71924100 @default.
• W1983212741 hasConcept C90924648 @default.
• W1983212741 hasConceptScore W1983212741C121608353 @default.
• W1983212741 hasConceptScore W1983212741C126322002 @default.
• W1983212741 hasConceptScore W1983212741C141071460 @default.
• W1983212741 hasConceptScore W1983212741C2776694085 @default.
• W1983212741 hasConceptScore W1983212741C2780259306 @default.
• W1983212741 hasConceptScore W1983212741C2780456651 @default.
• W1983212741 hasConceptScore W1983212741C29730261 @default.
• W1983212741 hasConceptScore W1983212741C44249647 @default.
• W1983212741 hasConceptScore W1983212741C526805850 @default.
• W1983212741 hasConceptScore W1983212741C71924100 @default.
• W1983212741 hasConceptScore W1983212741C90924648 @default.
• W1983212741 hasIssue "9" @default.
• W1983212741 hasLocation W19832127411 @default.
• W1983212741 hasLocation W19832127412 @default.
• W1983212741 hasOpenAccess W1983212741 @default.
• W1983212741 hasPrimaryLocation W19832127411 @default.
• W1983212741 hasRelatedWork W1970193197 @default.
• W1983212741 hasRelatedWork W1976118956 @default.
• W1983212741 hasRelatedWork W1986648508 @default.
• W1983212741 hasRelatedWork W2001881056 @default.
• W1983212741 hasRelatedWork W2010991676 @default.
• W1983212741 hasRelatedWork W2347320353 @default.
• W1983212741 hasRelatedWork W2399912137 @default.
• W1983212741 hasRelatedWork W2418260427 @default.
• W1983212741 hasRelatedWork W2766409029 @default.
• W1983212741 hasRelatedWork W2992854754 @default.
• W1983212741 hasVolume "15" @default.
• W1983212741 isParatext "false" @default.
• W1983212741 isRetracted "false" @default.
• W1983212741 magId "1983212741" @default.
• W1983212741 workType "article" @default.